HSDT: Helius Medical Technologies Inc - Class A Company Profile & Statistics

About

Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical Technologies, Inc. is based in Newtown, Pennsylvania.

Info & Links

CEO

Dane C. Andreeff

Headquarters

642 NEWTOWN YARDLEY ROAD, SUITE 100
NEWTOWN, PA 18940, UNITED STATES

Auditor

Baker Tilly US LLP

Share holders

Employees

Helius Medical Technologies Inc - Class A Statistics

Valuation Measures

Market Capitalization²

2.30M

Enterprise Value

-1.17M

Enterprise Value/EBITDA(ttm)

0.09

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

3.64

Price to Book(mrq)

0.46

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-47.44%

Operating Margin(ttm)

-1764.74%

Profit Margin(ttm)

-2689.18%

Return on Equity(ttm)

-244.82%

Return on Invested Capital(ttm)

-293.61%

Return on Assets(ttm)

-127.10%

Income Statement

Revenue(ttm)

502.00K

Revenue Per Share(ttm)

0.13

Gross Profit(ttm)

-16.00K

EBITDA(ttm)³

-12.93M

Net Income Available to Common(ttm)

-8.86M

Diluted EPS(ttm)

-6.18

Share Statistics

Beta (5Y Monthly)

1.68

52-Week Change

-92.43%

S&P 500 52-Week Change

25.69%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

3.73M

Dividend Yield

0.00%

Float⁴

3.54M

% Held by Insiders

5.10%

% Held by Institutions

18.63%

Balance Sheet

Total Cash(mrq)

3.47M

Total Cash Per Share(mrq)

0.93

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.61%

Quick Ratio(mrq)

3.10%

Book Value Per Share(mrq)

1.04

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.32

Free Cash Flow(ytd)

-8.67M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

HSDT

Helius Medical Technologies Inc - Class A

Helius Medical Technologies Inc - Class A Profile